Septerna, Inc Common Stock
Price & Volume
Stats
See more52W Range | $10.61-$38.04 |
Market Cap | $1.6B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $72.2M |
Revenue Growth (YoY) | 12,011% |
Gross Profit (12 Mos) | $72.2M |
Diluted EPS | -$0.80 |
News
See moreYahoo Finance • 15 days ago
Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?
Yahoo Finance • 18 days ago
Health Care had the best week vs. the S&P 500 on record
Yahoo Finance • 4 months ago
Septerna Reports Positive Phase 1 Data For SEP-631; Plans Phase 2 In CS Urticaria
About
CEO | Dr. Jeffrey T. Finer M.D., Ph.D. |
Address | 250 East Grand Avenue, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 130 |